All News | FDA

Advertising & Promotion

Feb 12, 2016
Washington Bill Requires Drug Makers To Report Costs of High-priced Drugs
Feb 11, 2016
Joint Paper Calls for Feds To Allow Pre-market Communication with Insurance Companies
Feb 10, 2016
Maryland Bills Seek Disclosure of Industry Financial Arrangements
Feb 8, 2016
FTC, Maine AG Settle Weight-Loss Supplement Case
Feb 3, 2016
New York Senate Resurrects Bill Requiring Marketing Reporting, Eliminating Ad Deduction
Feb 2, 2016
FDA Needs To Address Amarin Off-label Issues or Lose Its Authority: Internal Medicine Viewpoint
Jan 27, 2016
Study Examines Characteristics of Marketing Trials
Jan 26, 2016
Survey Finds Doctors Prefer Direct Touch
Jan 23, 2016
CDER Plans To Release Four Advertising Related Draft Guidances in 2016
Jan 21, 2016
First 2016 OPDP Untitled Letter Concerns YouTube Video

Good Clinical Practice

Dec 15, 2016
FDA, OHRP Issue Joint Electronic Informed Consent Guidance
Dec 14, 2016
OHRP 2017 International Human Research Standards Compilation Adds Six Nations
Dec 7, 2016
Ohio Senate Approves ‘Right-to-Try’ Bill
Dec 7, 2016
CIOMS Revises Ethical Research Guidelines
Dec 5, 2016
ABPI Finds Trial Result Disclosure for Approved Drugs Remains Steady in Europe
Dec 5, 2016
Researchers Find Patients Normally Excluded from Cancer Trials Respond Well
Dec 5, 2016
Group Looks To Optimize Exploratory Trials
Dec 2, 2016
Partnership Examines Cancer Trial Eligibility Criteria
Dec 2, 2016
Cures Bill Allows Consent Waiver for FDA Trials, Single IRB for Devices
Dec 2, 2016
EMA Analysis Finds Early Trial Design Can Aid Ultimate Development Success

FDA Regulation & Enforcement

Jun 5, 2019
OPDP Issues Second Untitled Letter for 2019
Jun 4, 2019
Major Statement Rule Pushed to 2020
Jun 4, 2019
Almirall Pays Feds, California $6.6 Million To Resolve Kickback Allegations
Jun 4, 2019
Three More States, D.C. Sue Purdue Pharma
May 29, 2019
Court: State Law Tort Claims Related to Knee Implant Device Approved Through PMA Are Preempted
May 29, 2019
FDA Is Closer to Regulating ‘Healthy,’ While ‘Natural’ Continues to Play Out in Court
May 28, 2019
New DOJ Corporate Compliance Program Guidance Shows How Prosecutors Scrutinize Companies’ Compliance Efforts
May 23, 2019
Supreme Court: Impossibility Preemption in Failure-To-Warn Cases Raises Question for a Judge, Not a Jury
May 23, 2019
Draft Guidance Would Allow Alternative Name for Potassium Chloride
May 20, 2019
Jury Finds for Allergan in False Advertising Case

Medical Devices

Jun 30, 2011
FDA Makes Enforcement, Compliance Histories Public
Jun 30, 2011
$3.4 Billion in Health Care Fraud-related Recoveries Expected in Just First Half of FY 2011, OIG Says
Jun 30, 2011
ReGen Biologics Sues FDA for Rescinding Clearance of Its Menaflex Collagen Scaffold
Jun 30, 2011
FDA, CMS Reviewing Regs To Eliminate Duplication
Jun 30, 2011
CAPA Leads Warning Letter Citations, FDA Says
Jun 30, 2011
FDA Keeping Eye on Products From Japan
May 31, 2011
STERIS Corp. Working With FDA To Review, Revise Promotional Materials for Certain Sterilization Devices
May 31, 2011
Outreach Has Its Drawbacks, Ombudsman Says
May 31, 2011
Postmarket Reforms Likely As Part of MDUFMA III
May 31, 2011
Industry Not Yet Sold on Database of Labeling, Photos

Copyright © Thompson FDA, a division of CBIS. All rights reserved.